Seelos Therapeutics Inc (SEEL)
0.72
+0.02
(+2.86%)
USD |
OTCM |
Nov 14, 16:00
Seelos Therapeutics Free Cash Flow (Quarterly): -0.972M for June 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -0.972M |
| March 31, 2024 | -4.642M |
| December 31, 2023 | -1.911M |
| September 30, 2023 | -5.749M |
| June 30, 2023 | -5.904M |
| March 31, 2023 | -10.35M |
| December 31, 2022 | -13.09M |
| September 30, 2022 | -11.07M |
| June 30, 2022 | -20.40M |
| March 31, 2022 | -17.04M |
| December 31, 2021 | -18.34M |
| September 30, 2021 | -10.51M |
| June 30, 2021 | -8.894M |
| March 31, 2021 | -11.25M |
| December 31, 2020 | -3.329M |
| September 30, 2020 | -4.18M |
| June 30, 2020 | -6.981M |
| March 31, 2020 | -6.423M |
| December 31, 2019 | -5.118M |
| September 30, 2019 | -2.91M |
| June 30, 2019 | -3.337M |
| March 31, 2019 | -7.94M |
| December 31, 2018 | -6.945M |
| September 30, 2018 | 2.684M |
| June 30, 2018 | -1.94M |
| Date | Value |
|---|---|
| March 31, 2018 | -1.928M |
| December 31, 2017 | -2.473M |
| September 30, 2017 | -3.028M |
| June 30, 2017 | -2.269M |
| March 31, 2017 | -2.696M |
| December 31, 2016 | -2.705M |
| September 30, 2016 | -0.861M |
| June 30, 2016 | -3.249M |
| March 31, 2016 | -6.271M |
| December 31, 2015 | -1.431M |
| September 30, 2015 | -6.622M |
| June 30, 2015 | -8.634M |
| March 31, 2015 | -6.292M |
| December 31, 2014 | -9.198M |
| September 30, 2014 | -4.145M |
| June 30, 2014 | -4.705M |
| March 31, 2014 | -0.547M |
| December 31, 2013 | 0.553M |
| September 30, 2013 | -4.21M |
| June 30, 2013 | -5.172M |
| March 31, 2013 | -6.809M |
| December 31, 2012 | -3.148M |
| September 30, 2012 | -2.901M |
| June 30, 2012 | -3.589M |
| March 31, 2012 | -5.18M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-20.40M
Minimum
Jun 2022
-0.972M
Maximum
Jun 2024
-8.745M
Average
-6.981M
Median
Jun 2020
Free Cash Flow (Quarterly) Benchmarks
| 180 Life Sciences Corp | 0.7272M |
| Cassava Sciences Inc | -18.31M |
| Cara Therapeutics Inc | -12.65M |
| Citius Pharmaceuticals Inc | -8.367M |
| Moleculin Biotech Inc | -6.113M |